Breaking News Instant updates and real-time market news.

CLVS

Clovis

$55.52

3.07 (5.85%)

09:01
04/09/18
04/09
09:01
04/09/18
09:01

Clovis price target raised to $90 from $85 at SunTrust

SunTrust analyst Peter Lawson raised his price target on Clovis to $90 after the company's Rubraca was approved for second line maintenance therapy in ovarian cancer. Lawson adds that while the approval was "mostly expected", his new price target reflects an increase in the probability of success and deeper conviction for further indicators, while also pointing to a generally broader use of PARP inhibitors. The analyst keeps his Buy rating on Clovis.

CLVS Clovis
$55.52

3.07 (5.85%)

04/06/18
PIPR
04/06/18
NO CHANGE
PIPR
Neutral
Clovis approval underscores rising competition facing Zejula, says Piper Jaffray
Prior to today's announcement that Clovis' (CLVS) label for its PARP inhibitor Rubraca has been expanded to include maintenance therapy in ovarian cancer, AstraZeneca's (AZN) Lynparza and Tesaro's (TSRO) Zejula were the only two PARP inhibitors approved in the maintenance setting, noted Piper Jaffray analyst Christopher Raymond. While Clovis' approval is not a surprise, it does underscore the intensifying competitive pressure facing Zejula, he said. Raymond, who said PARP inhibitors will primarily be differentiated on safety and added that this does not favor Zejula, keeps a Neutral rating on Tesaro.
02/27/18
RHCO
02/27/18
NO CHANGE
Target $85
RHCO
Buy
Clovis price target lowered to $85 from $95 at SunTrust
SunTrust analyst Peter Lawson lowered his price target on Clovis to $85 after the company's Q4 earnings, saying that since the revenues of Rubraca were "essentially flat", the Street was likely to reset growth expectations. The analyst adds that he has pushed back his view of commercialization in prostate and additional settings, but still believes the stock is "attractively positioned with reset revenues, and potentially positive news flows in the near term". Lawson keeps his Buy rating on Clovis.
02/27/18
LEHM
02/27/18
NO CHANGE
Target $85
LEHM
Overweight
Clovis price target lowered to $85 from $105 at Barclays
Barclays analyst Paul Choi lowered his price target for Clovis Oncology to $85 citing slower market transition to maintenance following the company's Q4 results. The analyst thinks the stock "will likely stay in a holding pattern" prior to the label expansion in the U.S. and an initial treatment indication approval in Europe, both of which are anticipated by Q2. Choi keeps an Overweight rating on Clovis shares.
02/22/18
02/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Palo Alto Networks (PANW) upgraded to Buy from Neutral at Cleveland Research with the firm saying it's channel partner checks indicate favorable revenue/billings growth in the low-20% range, versus high teens previously, and the product refresh could be a source of upside with increased hardware growth. 2. Verisk Analytics (VRSK) upgraded to Overweight from Neutral at JPMorgan with analyst Andrew Steinerman saying he believes sustainable high-single-digit organic revenue growth is "back in sight" following last night's "strong" fourth quarter results. 3. Tesaro (TSRO) upgraded to Outperform from In Line at Evercore ISI with analyst Steven Breazzano saying he believes the stocks' valuations are now attractive on a long-term basis following their pullbacks. 4. Clovis (CLVS) was upgraded to Outperform from In Line at Evercore ISI and to Outperform from Sector Perform at RBC Capital. 5. Wolverine World Wide (WWW) upgraded to Buy from Neutral at DA Davidson with analyst Andrew Burns saying the company is positioned for accelerating growth following a multi-year restructuring. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

09:25
11/20/18
11/20
09:25
11/20/18
09:25
Conference/Events
UBS leisure/lodging analyst to hold an analyst/industry conference call »

Leisure Analyst Farley…

GNUS

Genius Brands

$2.34

0.095 (4.24%)

09:24
11/20/18
11/20
09:24
11/20/18
09:24
Hot Stocks
Genius Brands CEO Andy Heyward issues letter to shareholders »

Genius Brands released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLIC

Kulicke & Soffa

$19.90

-0.96 (-4.60%)

09:23
11/20/18
11/20
09:23
11/20/18
09:23
Recommendations
Kulicke & Soffa analyst commentary  »

Kulicke & Soffa price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

NVDA

Nvidia

$144.66

-19.72 (-12.00%)

09:22
11/20/18
11/20
09:22
11/20/18
09:22
Downgrade
Nvidia rating change  »

Nvidia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

TLSA

Tiziana Therapeutics

$0.00

(0.00%)

09:21
11/20/18
11/20
09:21
11/20/18
09:21
Syndicate
Tiziana Therapeutics 443K share IPO priced at $9.90 »

Laidlaw acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TC

TuanChe

$0.00

(0.00%)

09:19
11/20/18
11/20
09:19
11/20/18
09:19
Syndicate
TuanChe 2.6M share IPO priced at $7.80 »

Maxim Group LLC and AMTD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

AAPL

Apple

$185.80

-7.62 (-3.94%)

09:19
11/20/18
11/20
09:19
11/20/18
09:19
Technical Analysis
Technical Take: Apple slides to six-month lows »

Apple (AAPL) was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/20/18
11/20
09:18
11/20/18
09:18
Options
Overnight activity included 450 trades in SPX and 83 trades in VIX »

450 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TESS

Tessco

$11.11

-0.12 (-1.07%)

09:17
11/20/18
11/20
09:17
11/20/18
09:17
Upgrade
Tessco rating change  »

Tessco assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

TC

Thompson Creek

$0.00

(0.00%)

09:17
11/20/18
11/20
09:17
11/20/18
09:17
Syndicate
Thompson Creek 2.6M share IPO priced at $7.80 »

Maxim Group LLC and AMTD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$35.29

-1.93 (-5.19%)

09:17
11/20/18
11/20
09:17
11/20/18
09:17
Recommendations
Boston Scientific analyst commentary  »

Boston Scientific price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

ORIT

Oritani Financial

$15.35

0.065 (0.43%)

09:17
11/20/18
11/20
09:17
11/20/18
09:17
Hot Stocks
Oritani Financial announces 15c special dividend »

Oritani Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

VST

Vistra Energy

$23.55

-0.12 (-0.51%)

09:16
11/20/18
11/20
09:16
11/20/18
09:16
Syndicate
Vistra Energy 12M share Block Trade priced at $23.20 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BLDR

Builders FirstSource

$12.55

0.11 (0.88%)

09:15
11/20/18
11/20
09:15
11/20/18
09:15
Conference/Events
Builders FirstSource management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 05

    Dec

09:15
11/20/18
11/20
09:15
11/20/18
09:15
General news
Lingering Strength for U.S. Producer Sentiment: »

Lingering Strength for…

MMAC

MMA Capital

$26.70

-0.3 (-1.11%)

09:14
11/20/18
11/20
09:14
11/20/18
09:14
Conference/Events
MMA Capital to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

WIFI

Boingo Wireless

$23.75

-0.55 (-2.26%)

09:13
11/20/18
11/20
09:13
11/20/18
09:13
Recommendations
Boingo Wireless analyst commentary  »

MTA of New York seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOR

Blucora

$28.87

-0.6 (-2.04%)

09:11
11/20/18
11/20
09:11
11/20/18
09:11
Conference/Events
Blucora management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

EB

Eventbrite

$28.99

-1.89 (-6.12%)

09:11
11/20/18
11/20
09:11
11/20/18
09:11
Hot Stocks
Eventbrite appoints Deborah Sharkey CCO, Crystal Valentine CDSO »

Eventbrite announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APH

Amphenol

$86.15

-2.57 (-2.90%)

09:11
11/20/18
11/20
09:11
11/20/18
09:11
Conference/Events
Amphenol management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AMRC

Ameresco

$14.39

-0.45 (-3.03%)

09:10
11/20/18
11/20
09:10
11/20/18
09:10
Conference/Events
Ameresco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AMBO

Ambow Education

$5.04

(0.00%)

09:10
11/20/18
11/20
09:10
11/20/18
09:10
Conference/Events
Ambow Education management to meet with Benchmark »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

TPNL

3PEA International

$3.90

0.12 (3.17%)

09:05
11/20/18
11/20
09:05
11/20/18
09:05
Hot Stocks
3PEA International appoints Dana Barciz as Chief Marketing Officer »

3PEA International named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$266.04

-5.21 (-1.92%)

09:05
11/20/18
11/20
09:05
11/20/18
09:05
Conference/Events
UnitedHealth to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

GE

General Electric

$7.84

-0.2 (-2.49%)

09:04
11/20/18
11/20
09:04
11/20/18
09:04
Hot Stocks
Dragos, GE launch collaboration to strengthen industrial control systems »

Dragos announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.